메뉴 건너뛰기




Volumn 34, Issue 7, 2017, Pages 886-908

Recent advances and perspectives in the design and development of polymyxins

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; POLYMYXIN;

EID: 85022178165     PISSN: 02650568     EISSN: 14604752     Source Type: Journal    
DOI: 10.1039/c7np00023e     Document Type: Review
Times cited : (108)

References (243)
  • 10
    • 85022230116 scopus 로고    scopus 로고
    • CDC webpage
    • CDC webpage, https://www.cdc.gov/drugresistance/about.html
  • 11
    • 84978180020 scopus 로고    scopus 로고
    • ed. T. G. Villa and M. Viñas, Springer International Publishing, Switzerland
    • F. Rabanal and Y. Cajal, in New Weapons to Control Bacterial Growth, ed., T. G. Villa, and, M. Viñas, Springer International Publishing, Switzerland, 2016, pp. 433-452
    • (2016) New Weapons to Control Bacterial Growth , pp. 433-452
    • Rabanal, F.1    Cajal, Y.2
  • 13
    • 85022225585 scopus 로고    scopus 로고
    • WHO press release
    • WHO press release, http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/
  • 21
    • 85022210281 scopus 로고    scopus 로고
    • K. Hayashi and T. Suzuki, Kyoto University Research information Repository, 1965
    • K. Hayashi and T. Suzuki, Kyoto University Research information Repository, 1965, http://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/76067/1/chd043-3-259.pdf
  • 49
    • 33744454666 scopus 로고    scopus 로고
    • Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
    • P. J. Bergen J. Li C. R. Rayner R. L. Nation Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa Antimicrob. Agents Chemother. 2006 50 1953 1958
    • (2006) Antimicrob. Agents Chemother. , vol.50 , pp. 1953-1958
    • Bergen, P.J.1    Li, J.2    Rayner, C.R.3    Nation, R.L.4
  • 54
    • 85022203062 scopus 로고    scopus 로고
    • European Medicines Agency review of polymyxin-based medicines
    • European Medicines Agency review of polymyxin-based medicines, http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2014/10/news-detail-002194.jsp&mid=WC0b01ac058004d5c1
  • 150
    • 85022180418 scopus 로고    scopus 로고
    • Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli, https://clinicaltrials.gov/ct2/show/NCT01732250
    • Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli, https://clinicaltrials.gov/ct2/show/NCT01597973, https://clinicaltrials.gov/ct2/show/NCT01732250
  • 212
    • 85022224584 scopus 로고    scopus 로고
    • patent aplication WO2010075416
    • R. A. Leese, patent aplication WO2010075416, 2010
    • (2010)
    • Leese, R.A.1
  • 216
    • 85022179080 scopus 로고    scopus 로고
    • 2nd International Conference on Polymyxins, September, 22-24, 2015 San Diego, California, USA
    • 2nd International Conference on Polymyxins, September, 22-24, 2015 San Diego, California, USA, http://www.isap.org/images/polymyxin-conference2015/Day-2-slides-session-8-2.pdf
  • 222
    • 85022175612 scopus 로고    scopus 로고
    • patent application WO2016/113470
    • M. Vaara and T. Vaara, patent application WO2016/113470, 2016
    • (2016)
    • Vaara, M.1    Vaara, T.2
  • 225
    • 85022183054 scopus 로고    scopus 로고
    • Start Up, 2015 (online journal), https://scrip.pharmamedtechbi.com/SC092696/Spero-Therapeutics-Remodeling-Antibiotics
    • D. Erickson, Start Up, 2015 (online journal) https://sperotherapeutics.com/wpcontent/uploads/2016/02/StartUP-Spero-Therapeutics-SU1512.pdf, https://scrip.pharmamedtechbi.com/SC092696/Spero-Therapeutics-Remodeling-Antibiotics
    • Erickson, D.1
  • 227
    • 85022198849 scopus 로고    scopus 로고
    • Spero press release
    • Spero press release, https://sperotherapeutics.com/news/press-releases/spero-therapeutics-initiates-first-clinical-study-lead-potentiator-candidate-treatment-multidrug-resistant-gram-negative-infections/
  • 234
    • 85022197722 scopus 로고    scopus 로고
    • Spero press release 2017
    • Spero press release 2017, https://sperotherapeutics.com/news/press-releases/spero-therapeutics-acquires-next-generation-antibacterial-candidates-pro-bono-bio-treatment-multidrug-resistant-gram-negative-infections/
  • 237
    • 85022209633 scopus 로고    scopus 로고
    • patent application WO2017/093210
    • F. Rabanal, patent application WO2017/093210, 2017
    • (2017)
    • Rabanal, F.1
  • 238
    • 85022221881 scopus 로고
    • patent US 3,450,687
    • D. C. Hobbs, patent US 3,450,687, 1969
    • (1969)
    • Hobbs, D.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.